1. Home
  2. LOVE vs PHAR Comparison

LOVE vs PHAR Comparison

Compare LOVE & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Lovesac Company

LOVE

The Lovesac Company

HOLD

Current Price

$14.52

Market Cap

177.7M

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.62

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOVE
PHAR
Founded
1998
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.7M
1.1B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
LOVE
PHAR
Price
$14.52
$16.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$27.60
$38.00
AVG Volume (30 Days)
593.6K
22.5K
Earning Date
12-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
5.90
N/A
EPS
0.46
0.00
Revenue
$690,559,000.00
$362,274,000.00
Revenue This Year
$6.93
$24.80
Revenue Next Year
$7.52
$6.84
P/E Ratio
$31.93
$2,946.57
Revenue Growth
0.13
26.78
52 Week Low
$11.26
$7.50
52 Week High
$28.21
$18.12

Technical Indicators

Market Signals
Indicator
LOVE
PHAR
Relative Strength Index (RSI) 56.69 51.06
Support Level $11.40 $16.23
Resistance Level $15.10 $17.00
Average True Range (ATR) 0.84 0.75
MACD 0.14 -0.16
Stochastic Oscillator 84.35 36.44

Price Performance

Historical Comparison
LOVE
PHAR

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: